Home    Contact    Sitemap    Search    
  Print page    
  

2010.03.08   Shares purchased by employees and notification of trade  [Stock Exchange Notice]
2010.02.19   Presentation 4th Quarter 2009  [Stock Exchange Notice]
2010.02.19   Results 4th quarter and full year 2009  [Stock Exchange Notice]
2010.02.16   Presentation of the annual report 2009  [Stock Exchange Notice]
2010.01.13   Hexvix® receives reimbursement approval in Germany  [Stock Exchange Notice]
2010.01.06   Inclusion completed in phase II study with Visonac™ for acne  [Stock Exchange Notice]
2010.01.06   Financial calendar 2010  [Stock Exchange Notice]
2009.12.31   Photocure received positive response from FDA on the New Drug Application (NDA) for Hexvix® for detection of bladder cancer  [Stock Exchange Notice]
2009.12.18   FDA Advisory Committee voted favourably to Hexvix® application in USA  [Stock Exchange Notice]
2009.11.26   Photocure granted patent in Europe and Russia for Visonac™ in the treatment of acne  [Stock Exchange Notice]
2009.11.25   Extraordinary General Meeting  [Stock Exchange Notice]
2009.11.23   Shares purchased by employees  [Stock Exchange Notice]
2009.11.20   FDA has posted an Advisory Committee meeting with Photocure to discuss Hexvix® NDA  [Stock Exchange Notice]
2009.11.03   Notice of extraordinary general meeting  [Stock Exchange Notice]
2009.10.28   Capital Markets Day Presentations  [Stock Exchange Notice]
2009.10.28   3rd quarter presentation  [Stock Exchange Notice]
2009.10.28   Share buy back and proposed extraordinary dividend of NOK 4.00/share  [Stock Exchange Notice]
2009.10.27   Information memorandum regarding Photocures divestment of Metvix®  [Stock Exchange Notice]
2009.10.20   Invitation to presentation of 3rd quarter report 2009 and Capital Markets Day  [Stock Exchange Notice]
2009.10.07   Photocure divests Metvix® to Galderma for EUR 51 million  [Stock Exchange Notice]
2009.10.01   Invitation to presentation of Photocure's divestment of Metvix®  [Stock Exchange Notice]
2009.10.01   Presentation of Photocures divestment of Metvix®  [Stock Exchange Notice]
2009.09.29   Market making agreement  [Stock Exchange Notice]
2009.08.14   Presentation 2nd quarter report  [Stock Exchange Notice]
2009.08.10   Presentation of the 2nd quarter 2009 report  [Stock Exchange Notice]


 
  Photocure ASA, Hoffsveien 48, NO-0377 Oslo, Norway. Telephone: +47 22 06 22 10 Fax: +47 22 06 22 18